Entry - #616544 - RETINITIS PIGMENTOSA 73; RP73 - OMIM
# 616544

RETINITIS PIGMENTOSA 73; RP73


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
8p11.21-p11.1 Retinitis pigmentosa 73 616544 AR 3 HGSNAT 610453
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
HEAD & NECK
Eyes
- Night blindness
- Visual field constriction
- Reduced red color vision (in some patients)
- Retinal atrophy
- Atrophy of retinal pigmented epithelium (RPE)
- Waxy disc pallor
- Small crystals in macula and midperiphery
- Pronounced choroidal vasculature
- Choroidal sclerosis
- Bone-spicule pigmentation in the midperiphery
- Attenuation of retinal vessels
- Diffuse atrophy of RPE on optical coherence tomography (OCT)
- Thinning of neurosensory retina in posterior pole on OCT
MISCELLANEOUS
- Variable age at onset of symptoms (from childhood to the sixth decade of life)
MOLECULAR BASIS
- Caused by mutation in the heparin-alpha-glucosaminide N-acetyltransferase gene (HGSNAT, 610453.0011)
Retinitis pigmentosa - PS268000 - 102 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.11 Retinitis pigmentosa 59 AR 3 613861 DHDDS 608172
1p36.11 ?Congenital disorder of glycosylation, type 1bb AR 3 613861 DHDDS 608172
1p34.1 Retinitis pigmentosa 76 AR 3 617123 POMGNT1 606822
1p31.3 Retinitis pigmentosa 20 AR 3 613794 RPE65 180069
1p31.3 Retinitis pigmentosa 87 with choroidal involvement AD 3 618697 RPE65 180069
1p22.1 Retinitis pigmentosa 19 AR 3 601718 ABCA4 601691
1p13.3 Retinitis pigmentosa 32 AR 3 609913 CLCC1 617539
1q21.2 Retinitis pigmentosa 18 AD 3 601414 PRPF3 607301
1q22 Retinitis pigmentosa 35 AR 3 610282 SEMA4A 607292
1q31.3 Retinitis pigmentosa-12 AR 3 600105 CRB1 604210
1q32.3 ?Retinitis pigmentosa 67 AR 3 615565 NEK2 604043
1q41 Retinitis pigmentosa 39 AR 3 613809 USH2A 608400
2p23.3 Retinitis pigmentosa 75 AR 3 617023 AGBL5 615900
2p23.3 ?Retinitis pigmentosa 58 AR 3 613617 ZNF513 613598
2p23.3 Retinitis pigmentosa 71 AR 3 616394 IFT172 607386
2p23.2 Retinitis pigmentosa 54 AR 3 613428 PCARE 613425
2p15 Retinitis pigmentosa 28 AR 3 606068 FAM161A 613596
2q11.2 Retinitis pigmentosa 33 AD 3 610359 SNRNP200 601664
2q13 Retinitis pigmentosa 38 AR 3 613862 MERTK 604705
2q31.3 Retinitis pigmentosa 26 AR 3 608380 CERKL 608381
2q37.1 Retinitis pigmentosa 47, autosomal recessive AR 3 613758 SAG 181031
2q37.1 Retinitis pigmentosa 96, autosomal dominant AD 3 620228 SAG 181031
3q11.2 Retinitis pigmentosa 55 AR 3 613575 ARL6 608845
3q12.3 Retinitis pigmentosa 56 AR 3 613581 IMPG2 607056
3q22.1 Retinitis pigmentosa 4, autosomal dominant or recessive AD, AR 3 613731 RHO 180380
3q25.1 Retinitis pigmentosa 61 3 614180 CLRN1 606397
3q26.2 Retinitis pigmentosa 68 AR 3 615725 SLC7A14 615720
4p16.3 Retinitis pigmentosa-40 AR 3 613801 PDE6B 180072
4p15.32 Retinitis pigmentosa 93 AR 3 619845 CC2D2A 612013
4p15.32 Retinitis pigmentosa 41 AR 3 612095 PROM1 604365
4p12 Retinitis pigmentosa 49 AR 3 613756 CNGA1 123825
4q32-q34 Retinitis pigmentosa 29 AR 2 612165 RP29 612165
5q32 Retinitis pigmentosa 43 AR 3 613810 PDE6A 180071
6p24.2 Retinitis pigmentosa 62 AR 3 614181 MAK 154235
6p21.31 Retinitis pigmentosa 14 AR 3 600132 TULP1 602280
6p21.1 Retinitis pigmentosa 48 AD 3 613827 GUCA1B 602275
6p21.1 Leber congenital amaurosis 18 AD, AR, DD 3 608133 PRPH2 179605
6p21.1 Retinitis pigmentosa 7 and digenic form AD, AR, DD 3 608133 PRPH2 179605
6q12 Retinitis pigmentosa 25 AR 3 602772 EYS 612424
6q14.1 Retinitis pigmentosa 91 AD 3 153870 IMPG1 602870
6q23 Retinitis pigmentosa 63 AD 2 614494 RP63 614494
7p21.1 ?Retinitis pigmentosa 85 AR 3 618345 AHR 600253
7p15.3 Retinitis pigmentosa 42 AD 3 612943 KLHL7 611119
7p14.3 ?Retinitis pigmentosa 9 AD 3 180104 RP9 607331
7q32.1 Retinitis pigmentosa 10 AD 3 180105 IMPDH1 146690
7q34 Retinitis pigmentosa 86 AR 3 618613 KIAA1549 613344
8p23.1 Retinitis pigmentosa 88 AR 3 618826 RP1L1 608581
8p11.21-p11.1 Retinitis pigmentosa 73 AR 3 616544 HGSNAT 610453
8q11.23-q12.1 Retinitis pigmentosa 1 AD, AR 3 180100 RP1 603937
8q22.1 Cone-rod dystrophy 16 AR 3 614500 CFAP418 614477
8q22.1 Retinitis pigmentosa 64 AR 3 614500 CFAP418 614477
9p21.1 Retinitis pigmentosa 31 AD 3 609923 TOPORS 609507
9q32 Retinitis pigmentosa 70 AD 3 615922 PRPF4 607795
10q11.22 ?Retinitis pigmentosa 66 AR 3 615233 RBP3 180290
10q22.1 Retinitis pigmentosa 92 AR 3 619614 HKDC1 617221
10q22.1 Retinitis pigmentosa 79 AD 3 617460 HK1 142600
10q23.1 Retinitis pigmentosa 65 AR 3 613660 CDHR1 609502
10q23.1 Cone-rod dystrophy 15 AR 3 613660 CDHR1 609502
10q23.1 Macular dystrophy, retinal AR 3 613660 CDHR1 609502
10q23.1 Retinitis pigmentosa 44 3 613769 RGR 600342
10q24.32 Retinitis pigmentosa 83 AD 3 618173 ARL3 604695
11p11.2 Retinitis pigmentosa 72 AR 3 616469 ZNF408 616454
11q12.2 Retinitis pigmentosa 98 AR 3 620996 TMEM216 613277
11q12.3 Retinitis pigmentosa-50 3 613194 BEST1 607854
11q12.3 Retinitis pigmentosa, concentric 3 613194 BEST1 607854
11q12.3 Retinitis pigmentosa 7, digenic form AD, AR, DD 3 608133 ROM1 180721
13q14.11 ?Retinitis pigmentosa 97 AD 3 620422 VWA8 617509
14q11.2-q12 Retinitis pigmentosa 27 AD 3 613750 NRL 162080
14q24.1 Leber congenital amaurosis 13 AD, AR 3 612712 RDH12 608830
14q24.3 ?Retinitis pigmentosa 81 AR 3 617871 IFT43 614068
14q31.3 Retinitis pigmentosa 94, variable age at onset, autosomal recessive AR 3 604232 SPATA7 609868
14q31.3 Leber congenital amaurosis 3 AR 3 604232 SPATA7 609868
14q31.3 ?Retinitis pigmentosa 51 AR 3 613464 TTC8 608132
15q23 Retinitis pigmentosa 37 AD, AR 3 611131 NR2E3 604485
15q25.1 Retinitis pigmentosa 90 AR 3 619007 IDH3A 601149
16p13.3 Retinitis pigmentosa 80 AR 3 617781 IFT140 614620
16p12.3-p12.1 Retinitis pigmentosa 22 2 602594 RP22 602594
16q13 Retinitis pigmentosa 74 AR 3 616562 BBS2 606151
16q13 Retinitis pigmentosa 82 with or without situs inversus AR 3 615434 ARL2BP 615407
16q21 Retinitis pigmentosa 45 AR 3 613767 CNGB1 600724
16q22.2 Retinitis pigmentosa 84 AR 3 618220 DHX38 605584
17p13.3 Retinitis pigmentosa 13 AD 3 600059 PRPF8 607300
17q23.2 Retinitis pigmentosa 17 AD 4 600852 RP17 600852
17q25.1 Retinitis pigmentosa 36 3 610599 PRCD 610598
17q25.3 Retinitis pigmentosa 30 3 607921 FSCN2 607643
17q25.3 Retinitis pigmentosa 57 AR 3 613582 PDE6G 180073
19p13.3 Retinitis pigmentosa 77 AR 3 617304 REEP6 609346
19p13.3 Retinitis pigmentosa 95 AR 3 620102 RAX2 610362
19p13.2 Retinitis pigmentosa 78 AR 3 617433 ARHGEF18 616432
19q13.42 Retinitis pigmentosa 11 AD 3 600138 PRPF31 606419
20p13 Retinitis pigmentosa 46 AR 3 612572 IDH3B 604526
20p11.23 Retinitis pigmentosa 69 AR 3 615780 KIZ 615757
20q11.21 Retinitis pigmentosa 89 AD 3 618955 KIF3B 603754
20q13.33 Retinitis pigmentosa 60 AD 3 613983 PRPF6 613979
Xp22.2 ?Retinitis pigmentosa 23 XLR 3 300424 OFD1 300170
Xp21.3-p21.2 ?Retinitis pigmentosa, X-linked recessive, 6 XL 2 312612 RP6 312612
Xp11.4 Retinitis pigmentosa 3 XL 3 300029 RPGR 312610
Xp11.3 Retinitis pigmentosa 2 XL 3 312600 RP2 300757
Xq26-q27 Retinitis pigmentosa 24 2 300155 RP24 300155
Xq28 Retinitis pigmentosa 34 2 300605 RP34 300605
Chr.Y Retinitis pigmentosa, Y-linked YL 2 400004 RPY 400004
Not Mapped Retinitis pigmentosa AR 268000 RP 268000

TEXT

A number sign (#) is used with this entry because of evidence that retinitis pigmentosa-73 (RP73) is caused by homozygous mutation in the HGSNAT gene (610453) on chromosome 8p11.

Mutation in the HGSNAT gene also causes mucopolysaccharidosis type IIIC (252930), the features of which include late-onset RP.

For a general phenotypic description and a discussion of genetic heterogeneity of retinitis pigmentosa, see 268000.


Clinical Features

Haer-Wigman et al. (2015) studied 3 affected individuals from 2 Ashkenazi Jewish Israeli families and 3 sibs from a Dutch family with nonsyndromic retinitis pigmentosa. All had night blindness and/or visual field loss as initial symptoms, but in the Israeli families, the 3 patients noted onset in childhood or adolescence and were diagnosed with RP in the fourth decade of life, whereas in the Dutch family, onset of symptoms did not occur until the fifth or sixth decade of life. The proband from the first Ashkenazi Jewish family was diagnosed at age 34 years, at which time full-field electroretinography (ERG) responses were undectectable. By age 60, her visual acuity was severely reduced bilaterally, and funduscopy showed severe and extensive atrophic changes of the retina and the retinal pigmented epithelium (RPE). In addition, choroidal sclerosis was observed, particularly at the posterior pole, accompanied by bone-spicule pigmentation at the midperiphery, with sparse and narrow retinal blood vessels. Examination of the 2 affected brothers from the other Ashkenazi family at ages 29 and 30 years showed reduced visual acuity, peripapillary atrophy, small macular crystals, and pronounced choroidal vasculature. Visual fields showed peripheral constriction bilaterally, and ERGs showed severe generalized rod-cone dysfunction with an electronegative pattern. In the Dutch family, 2 of the 3 affected sibs had reduced red color vision in addition to typical findings of retinitis pigmentosa. Comprehensive examination of affected individuals from all 3 families revealed no extraocular abnormalities, apart from mild hearing impairment at age 59 years in the Ashkenazi woman.


Inheritance

The transmission pattern of RP73 in the families reported by Haer-Wigman et al. (2015) was consistent with autosomal recessive inheritance.


Molecular Genetics

In a 60-year-old woman with nonsyndromic RP from a consanguineous Ashkenazi Jewish family, who was negative for several common founder mutations underlying RP in this population, Haer-Wigman et al. (2015) performed whole-exome sequencing and identified homozygosity for a missense mutation in the HGSNAT gene (R124W; 610453.0011) that segregated with disease in the family. Screening for the HGSNAT mutation in a panel of 66 Ashkenazi Jewish nonsyndromic RP patients who had previously been found negative for known RP-causing Ashkenazi Jewish founder mutations revealed 1 patient who was homozygous for R124W, which was not found in 211 controls of the same population. His affected brother was also homozygous for the mutation. In addition, whole-exome sequencing in 3 affected sibs from a Dutch family with RP identified homozygosity for a missense mutation (A615T; 610453.0012) as well as heterozygosity for another missense mutation (G133A; 610453.0013) in HGSNAT.


REFERENCES

  1. Haer-Wigman, L., Newman, H., Leibu, R., Bax, N. M., Baris, H. N., Rizel, L., Banin, E., Massarweh, A., Roosing, S., Lefeber, D. J., Zonneveld-Vrieling, M. N., Isakov, O., Shomron, N., Sharon, D., Den Hollander, A. I., Hoyng, C. B., Cremers, F. P. M., Ben-Yosef, T. Non-syndromic retinitis pigmentosa due to mutations in the mucopolysaccharidosis type IIIC gene, heparan-alpha-glucosaminide N-acetyltransferase (HGSNAT). Hum. Molec. Genet. 24: 3742-3751, 2015. [PubMed: 25859010, images, related citations] [Full Text]


Creation Date:
Marla J. F. O'Neill : 9/4/2015
carol : 12/19/2022
carol : 09/08/2015

# 616544

RETINITIS PIGMENTOSA 73; RP73


ORPHA: 791;   DO: 0110389;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
8p11.21-p11.1 Retinitis pigmentosa 73 616544 Autosomal recessive 3 HGSNAT 610453

TEXT

A number sign (#) is used with this entry because of evidence that retinitis pigmentosa-73 (RP73) is caused by homozygous mutation in the HGSNAT gene (610453) on chromosome 8p11.

Mutation in the HGSNAT gene also causes mucopolysaccharidosis type IIIC (252930), the features of which include late-onset RP.

For a general phenotypic description and a discussion of genetic heterogeneity of retinitis pigmentosa, see 268000.


Clinical Features

Haer-Wigman et al. (2015) studied 3 affected individuals from 2 Ashkenazi Jewish Israeli families and 3 sibs from a Dutch family with nonsyndromic retinitis pigmentosa. All had night blindness and/or visual field loss as initial symptoms, but in the Israeli families, the 3 patients noted onset in childhood or adolescence and were diagnosed with RP in the fourth decade of life, whereas in the Dutch family, onset of symptoms did not occur until the fifth or sixth decade of life. The proband from the first Ashkenazi Jewish family was diagnosed at age 34 years, at which time full-field electroretinography (ERG) responses were undectectable. By age 60, her visual acuity was severely reduced bilaterally, and funduscopy showed severe and extensive atrophic changes of the retina and the retinal pigmented epithelium (RPE). In addition, choroidal sclerosis was observed, particularly at the posterior pole, accompanied by bone-spicule pigmentation at the midperiphery, with sparse and narrow retinal blood vessels. Examination of the 2 affected brothers from the other Ashkenazi family at ages 29 and 30 years showed reduced visual acuity, peripapillary atrophy, small macular crystals, and pronounced choroidal vasculature. Visual fields showed peripheral constriction bilaterally, and ERGs showed severe generalized rod-cone dysfunction with an electronegative pattern. In the Dutch family, 2 of the 3 affected sibs had reduced red color vision in addition to typical findings of retinitis pigmentosa. Comprehensive examination of affected individuals from all 3 families revealed no extraocular abnormalities, apart from mild hearing impairment at age 59 years in the Ashkenazi woman.


Inheritance

The transmission pattern of RP73 in the families reported by Haer-Wigman et al. (2015) was consistent with autosomal recessive inheritance.


Molecular Genetics

In a 60-year-old woman with nonsyndromic RP from a consanguineous Ashkenazi Jewish family, who was negative for several common founder mutations underlying RP in this population, Haer-Wigman et al. (2015) performed whole-exome sequencing and identified homozygosity for a missense mutation in the HGSNAT gene (R124W; 610453.0011) that segregated with disease in the family. Screening for the HGSNAT mutation in a panel of 66 Ashkenazi Jewish nonsyndromic RP patients who had previously been found negative for known RP-causing Ashkenazi Jewish founder mutations revealed 1 patient who was homozygous for R124W, which was not found in 211 controls of the same population. His affected brother was also homozygous for the mutation. In addition, whole-exome sequencing in 3 affected sibs from a Dutch family with RP identified homozygosity for a missense mutation (A615T; 610453.0012) as well as heterozygosity for another missense mutation (G133A; 610453.0013) in HGSNAT.


REFERENCES

  1. Haer-Wigman, L., Newman, H., Leibu, R., Bax, N. M., Baris, H. N., Rizel, L., Banin, E., Massarweh, A., Roosing, S., Lefeber, D. J., Zonneveld-Vrieling, M. N., Isakov, O., Shomron, N., Sharon, D., Den Hollander, A. I., Hoyng, C. B., Cremers, F. P. M., Ben-Yosef, T. Non-syndromic retinitis pigmentosa due to mutations in the mucopolysaccharidosis type IIIC gene, heparan-alpha-glucosaminide N-acetyltransferase (HGSNAT). Hum. Molec. Genet. 24: 3742-3751, 2015. [PubMed: 25859010] [Full Text: https://doi.org/10.1093/hmg/ddv118]


Creation Date:
Marla J. F. O'Neill : 9/4/2015

Edit History:
carol : 12/19/2022
carol : 09/08/2015